By Denny Jacob
Medical aesthetics company Sientra’s AlloX2 Pro Tissue Expander received 510k-clearance from the U.S. Food and Drug Administration. Shares rocket 93% in aftermarket trading.
Elevation Oncology proposed an underwritten public offering. Shares tumble 26% in after-hours trading.
Unico American’s operating unit was placed into conservation in California, and Unico’s stock will be delisted from Nasdaq. Shares slide 40% in aftermarket trading.
Write to Denny Jacob at denny.jacob@wsj.com
Read the full article here